Villar J, Say L, Gulmezoglu AM, et al. Eclampsia and pre-eclampsia: a health problem for 2000 years. In: Critchly H, MacLean A, Poston L, Walker J, editors. Preeclampsia. London: RCOG Press; 2003. p. 189–207.
Ronsmans C, Graham WJ. On behalf of the Lancet Maternal Survival Series Steering Group. Maternal mortality: who, when, where, and why. Lancet. 2006;368:1189–200.
Roberts CL, Ford JB, Algert CS, et al. Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study. BMJ Open. 2011;1:e000101.
GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–71.
Alkema L, Chou D, Hogan D, Zhang S, Moller AB, Gemmill A, et al. Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group. Lancet. 2016;387(10017):462–74.
Akar ME, Eyi EG, Yilmaz ES, Yuksel B, Yilmaz Z. Maternal deaths and their causes in Ankara, Turkey, 1982–2001. J Health Popul Nutr. 2004;22(4):420–8.
Koopmans CM, Bijlenga D, Groen H, Vijgen SMC, Aarnoudse JG, Bekedam DJ, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009;374:979–88.
American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the ACOG’s Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122–31.
Dubowitz LM, Dubowitz V, Goldberg C. Clinical assesment of gestational age in the newborn. J Pediatr. 1970;77:1–10.
Clark SL, Belfort MA, Dildy GA, et al. Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. Am J Obstet Gynecol. 2008;199:36.e1–5.
Harmon QE, Huang L, Umbach DM, Klungsøyr K, Engel SM, Magnus P, et al. Risk of fetal death with preeclampsia. Obstet Gynecol. 2015;125(3):628–35.
Cunningham FG, Leveno KJ, Bloom SL, et al. Hypertensive disorders of pregnancy. In:Willams Obstetrics. 24th ed. New York: McGraw-Hill; 2014. p. 728–80.
Zhang J, Meikle S, Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy. 2003;22:203–12.
Thornton CE, Makris A, Ogle RF, Tooher JM, Hennessy A. Role of proteinuria in defining preeclampsia: clinical outcomes for women and babies. Clin Exp Pharmacol Physiol. 2010;37(4):466–70.
Schiff E, Friedman SA, Kao L, Sibai BM. The importance of urinary protein excretion during conservative management of severe pre-eclampsia. Am J Obstet Gynecol. 1996;175:1313–6.
Maybury H, Waugh J. Proteinuria in pregnancy: just what is significant? Fetal Matern Med Rev. 2004;16:71–95.
Ferrazzani S, Caruso A, De Carolis S, Martino IV, Mancuso S. Proteinuria and outcome of 444 pregnancies complicated by hypertension. Am J Obstet Gynecol. 1990;162:366–71.
Lindheimer, Marshall D, Kanter D. Interpreting abnormal proteinuria in pregnancy: the need for a more pathophysiological approach. Obstet Gynecol. 2010;115(2 Part 1):365–75.